Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation

Acquired hemophilia A is an uncommon disease often presented with bleeding episodes causing a significant mortality risk. The main responsible for the threatening hemorrhagic disorder is the Factor VIII autoantibody's development. Acquired inhibitors' presence is frequently idiopathic, but it can be associated with malignancy, pregnancy, drugs and autoimmune diseases. In this report, we present the first case of acquired hemophilia A associated with primary biliary cholangitis. A 48-year-old man, presented with diffuse oral bleeding after a tooth extraction. Hemostasis testing revealed a markedly prolonged activated partial thromboplastin time. The search for an anti-factor VIII inhibitor returned positive. The etiological investigation concluded primary biliary cholangitis, and the patient was treated with bypassing agent, immunosuppressive therapy, and ursodeoxycholic acid.

Authors

Institutions

Publication Details

Journal
Future Science OA
Published
2025-04-07
DOI
https://doi.org/10.1080/20565623.2025.2489329
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation

Choumous Kallel, Hatem Masmoudi, Nour Siala, Imen Krichen et al.
Future Science OA
Hemophilia Treatment and Research
article

Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation

Choumous Kallel, Hatem Masmoudi, Nour Siala, Imen Krichen, Fatma Megdiche, Imen Frikha, H. Hachicha, Maha Charfi, Moez Medhaffar, Faten Kallel, N. Kallel, Moez Elloumi
article en

Abstract

Acquired hemophilia A is an uncommon disease often presented with bleeding episodes causing a significant mortality risk. The main responsible for the threatening hemorrhagic disorder is the Factor VIII autoantibody's development. Acquired inhibitors' presence is frequently idiopathic, but it can be associated with malignancy, pregnancy, drugs and autoimmune diseases. In this report, we present the first case of acquired hemophilia A associated with primary biliary cholangitis. A 48-year-old man, presented with diffuse oral bleeding after a tooth extraction. Hemostasis testing revealed a markedly prolonged activated partial thromboplastin time. The search for an anti-factor VIII inhibitor returned positive. The etiological investigation concluded primary biliary cholangitis, and the patient was treated with bypassing agent, immunosuppressive therapy, and ursodeoxycholic acid.

Future Science OAVol. 11(1)
Hopital Universitaire Hedi Chaker (TN), Hopital Universitaire Habib Bourguiba (TN)
Openalex Percentile: Top 91%
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation — Choumous Kallel, Hatem Masmoudi, et al. · Future Science OA (2025) | TGRS Research Map | TGRS